Our portfolio

Caelus Health

Specializing in microbiota-based products, Caelus Health targets cardiometabolic diseases. Their research focuses on beneficial bacterial strains that improve insulin sensitivity and metabolic health. Their first product is a precision probiotic supplement for prediabetes and type 2 diabetes.

Industry: Metabolic Disorders, Microbiome

Want to get in contact about Caelus Health?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Enhancing plant growth with solar-powered nanotechnology.
Developing adaptive online learning systems.
Adding the size dimension to optical spectroscopy.
Modulating immune responses with glycan-modified antigens for autoimmune and oncology treatments.
Enhancing plant growth with solar-powered nanotechnology.
Developing adaptive online learning systems.
Adding the size dimension to optical spectroscopy.
Modulating immune responses with glycan-modified antigens for autoimmune and oncology treatments.